National Research (NRC) – Research Analysts’ Weekly Ratings Updates

National Research (NASDAQ: NRC) recently received a number of ratings updates from brokerages and research firms:

  • 11/12/2026 – National Research was upgraded by Weiss Ratings from “hold (c-)” to “hold (c)”.
  • 11/7/2026 – National Research was upgraded by Wall Street Zen from “hold” to “buy”.
  • 10/28/2026 – National Research was upgraded by Weiss Ratings from “sell (d+)” to “hold (c-)”.
  • 10/28/2026 – National Research had its price target raised by Citizens Jmp from $26.00 to $27.00. They now have a “market outperform” rating on the stock.
  • 10/9/2026 – National Research was downgraded by Weiss Ratings from “hold (c-)” to “sell (d+)”.
  • 10/5/2026 – National Research was upgraded by Zacks Research to “hold”.

National Research Stock Performance

Shares of NASDAQ:NRC traded down $0.17 during trading on Wednesday, hitting $25.72. The company’s stock had a trading volume of 7,362 shares, compared to its average volume of 112,274. The company has a 50-day moving average of $22.32 and a 200-day moving average of $19.50. The company has a debt-to-equity ratio of 13.13, a current ratio of 0.64 and a quick ratio of 0.64. The firm has a market cap of $545.80 million, a price-to-earnings ratio of 91.86 and a beta of 0.22. National Research Corporation has a 12 month low of $11.73 and a 12 month high of $27.60.

National Research (NASDAQ:NRC – Get Free Report) last released its earnings results on Tuesday, October 27th. The company reported $0.21 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.18 by $0.03. National Research had a net margin of 4.48% and a return on equity of 313.25%. The company had revenue of $38.40 million during the quarter, compared to analyst estimates of $35.80 million. On average, sell-side analysts expect that National Research Corporation will post 0.97 earnings per share for the current year.

National Research Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, January 8th. Stockholders of record on Tuesday, December 29th will be given a dividend of $0.16 per share. This represents a $0.64 dividend on an annualized basis and a dividend yield of 2.5%. The ex-dividend date is Tuesday, December 29th. National Research’s dividend payout ratio is currently 228.57%.

National Research Corporation, which operates as NRC Health, provides experience-management and consumer-insights services to organizations in the health care industry. Its research and technology help clients understand how patients, health care consumers and employees perceive their services. The company’s offerings include patient and consumer surveys, employee-engagement research, reputation measurement, analytics and related advisory services. Hospitals, health systems and other health care organizations use these tools to identify opportunities to improve service and strengthen relationships with the communities they serve.

Read More

Receive News & Ratings for National Research Corporation Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Research Corporation and related companies with MarketBeat.com's FREE daily email newsletter.